Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted from Prograf® to Advagraf®

Trial Identifier: PMR-EC-1206
Sponsor: Astellas Pharma Europe Ltd.
Start Date: May 2011
Primary Completion Date: October 2015
Study Completion Date: November 2025
Condition: Heart Transplants; Kidney Transplants; Intestine Transplants; Liver Transplants; Lung Transplants

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Belgium Brussels, Belgium, 1200
Belgium Brussels, Belgium, 1020
Czech Republic Prague 5, Czech Republic, 150 06
France Bron Cedex, France, 69677
France BRON Cedex, France, 69677
France Paris Cedex 15, France, 75908
France Paris Cedex 15, France, 75743
Germany Heidelberg, Germany, 69120
Italy Bergamo, Italy, 24127
Italy Palermo, Italy, 90127
Poland Warsaw, Poland, 04-730
United Kingdom Birmingham, United Kingdom, B4 6NH
United Kingdom London, United Kingdom, WC1 3JH
United Kingdom Manchester, United Kingdom, M27 4HA